ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
New mechanisms for antibiotic reimbursement in the United States: CMS’s IPPS FY2020 Final Rule
In Praise of Non-Inferiority
FDA analysis of 40-years of antibacterial development: Dheman et al.
The 6 meanings of “Lack of Access” (UNSLAP)
FDA Workshop: Animal Models To Support Antibacterial Development (5 Mar 2020, post-meeting notes)
Two new oral drugs for gonorrhea!
Limits on measuring the impact of rapid antimicrobial susceptibility testing (AST)
De-risking vaccine development: Insights spanning decades of experience
Assessing antibiotic value: DTR, fire extinguishers, and a view from Australia
COVID-19 and the Long-Term Trajectory of AMR Efforts: Wellcome Trust Deep Dive
UK to expand NHS Subscription Pilot! Consultation Period launches
News from Davos 2020: Some positive signs, but overall a fragile antibiotic market at a tipping point
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet












